PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial
Juan Pablo Alderuccio, Isildinha M. Reis, Mehdi Hamadani, Muthiah Nachiappan, Salman Leslom, Brad S. Kahl, Weiyun Z. Ai, John Radford, Melhem Solh, Kirit M. Ardeshna, Brian T. Hess, Matthew A. Lunning, Pier Luigi Zinzani, Anastasios Stathis, Carmelo Carlo-Stella, Izidore S. Lossos, Paolo F. Caimi, Sunwoo Han, Fei Yang, Russ A. KukerCraig H. Moskowitz
Dive into the research topics of 'PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial'. Together they form a unique fingerprint.